Justine Cohen, DO
Dana-Farber Cancer Institute
BIOGRAPHY
Justine V. Cohen is a medical oncologist at Dana-Farber Cancer Institute. She is a clinical and translational investigator specializing in the treatment of patients with cutaneous malignancies including malignant melanoma, squamous cell carcinoma, Merkel cell carcinoma and other rare cutaneous malignancies. She completed a mid-career fellowship in Hospice and Palliative Medicine and she serves as the lead physician for cutaneous malignancies in the Center for Cancer Therapeutic Innovation (Early Drug Development Program). Her experience as a clinical investigator includes enrolling patients on clinical trials with the goal of developing novel therapies and combinations of immunotherapies and targeted therapies to treat melanoma and non-melanoma skin cancers while minimizing toxicity and maximizing quality of life. Dr. Cohen’s background combines clinical research, patient care, and humanities in medicine.
SESSIONS
HANDOUTS
DISCLOSURES
Bristol-Myers Squibb – Advisory Board(Honoraria); Replimune – Advisory Board(Honoraria);